Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Investors are clearly excited about a NASDAQ IPO by a biotech company developing a dual GLP-1/GIP agonist to treat obesity, which is scheduled for June 2025
As you can see from the side-by-side Figure below, the new trial (at left) replicates the previous one for symptomatic benefit and reduced physical limitations (Y-axis, corresponding to the Kansas City score) with the primary endpoint findings remarkably similar
A Wegovy pill introduced in January has had the strongest launch of any obesity drug to date, while Novo has also introduced a subscription program offering lower monthly prices for the drug
For meal prep, the gel cube method is most convenientmake a full weeks worth in a single batch, pour it into a shallow pan or ice cube trays, refrigerate until firm, then cut or pop out individual portions
If youre trying to lose weight or youve already tried GLP-1 medications, a weight loss patch can sound like a dream come true
US$ 24.94
US$ 28.90
US$ 27.06
US$ 23.35
